2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4363):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-59121A
    Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate
    Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate can be used to synthesis Sofosbuvir (HY-15005) to avoid the production of sofibuvir degradation impurities.
    Isopropyl ((R)-(perfluorophenoxy)(phenoxy)phosphoryl)-L-alaninate
  • HY-W007501
    2-Bromo-3-methoxypyridine
    		99.88%
    2-Bromo-3-methoxypyridine is a drug intermediate that can be used for the synthesis of the metabolite of Piroxicam (HY-B0253).
    2-Bromo-3-methoxypyridine
  • HY-W022810
    Candesartan impurity 26
    Candesartan impurity 26 is an impurity of Candesartan.
    Candesartan impurity 26
  • HY-W425682
    Fmoc-L-Penicillamine
    Fmoc-L-Penicillamine is formed by the connection of the Fmoc protecting group and L-Penicillamine through a specific chemical bond. Fmoc-L-Penicillamine plays an important role in organic synthesis, especially in the field of peptide synthesis.
    Fmoc-L-Penicillamine
  • HY-W416427
    Paliperidone impurity 9
    Paliperidone impurity 9 is an impurity of Paliperidone.
    Paliperidone impurity 9
  • HY-76408
    (1S,2S)-2-((R)-1-Phenylethylamino)cyclohexanol
    		98.0%
    (1S,2S)-2-((R)-1-Phenylethylamino)cyclohexanol is a drug intermediate for synthesis of various active compounds.
    (1S,2S)-2-((R)-1-Phenylethylamino)cyclohexanol
  • HY-21984
    3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid
    		98.30%
    3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid is a drug intermediate for synthesis of various active compounds.
    3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid
  • HY-Z8081
    Dutasteride impurity 1
    Dutasteride Impurity 1 is an impurity of Dutasteride (HY-13613).
    Dutasteride impurity 1
  • HY-I0461
    Apixaban impurity 46
    Apixaban impurity 46 is an impurity of Apixaban.
    Apixaban impurity 46
  • HY-24325
    3-(3,5-Dichlorophenyl)-1-methylhydantoin
    3-(3,5-Dichlorophenyl)-1-methylhydantoin is a drug intermediate for synthesis of various active compounds.
    3-(3,5-Dichlorophenyl)-1-methylhydantoin
  • HY-Y1190
    2-Chloro-5-nitrobenzoic acid
    2-Chloro-5-nitrobenzoic acid (Mesalazine impurity 1) is an impurity of 2-Chloro-5-nitrobenzoic acid.
    2-Chloro-5-nitrobenzoic acid
  • HY-W250457
    Ondansetron impurity 6
    Ondansetron impurity 6 is an impurity of Ondansetron.
    Ondansetron impurity 6
  • HY-77304
    2-Methyl-2-propanyl(1S,8R)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate
    2-Methyl-2-propanyl(1S,8R)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate (6-Nitro-(1R,4S)-1,2,3,4-tetrahydro-1,4-epiazano-naphthalene-9-carboxylic acid tert-butyl ester-10) is a drug intermediate for synthesis of various active compounds.
    2-Methyl-2-propanyl(1S,8R)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate
  • HY-Z0779
    Methyl 2-formyl-5-methoxybenzoate
    		99.86%
    Methyl 2-formyl-5-methoxybenzoate is a drug impurity.
    Methyl 2-formyl-5-methoxybenzoate
  • HY-Z0450
    Methyl 5-formylsalicylate
    		99.95%
    Methyl 5-formylsalicylate is a drug impurity.
    Methyl 5-formylsalicylate
  • HY-179477
    Fmoc-β-Ala-Asp(OMpe)-OH
    Fmoc-β-Ala-Asp(OMpe)-OH is a specialized amino acid derivative used in solid-phase peptide synthesis (SPPS). Fmoc-β-Ala-Asp(OMpe)-OH consists of a beta-alanine spacer linked to an aspartic acid residue, where the beta-carboxyl group is protected with a 3-methylpentyl ester (OMpe) to prevent aspartimide formation during synthesis. Fmoc-β-Ala-Asp(OMpe)-OH a useful building block for creating peptides that contain aspartic acid, as the OMpe group is designed to minimize unwanted side reactions.
    Fmoc-β-Ala-Asp(OMpe)-OH
  • HY-W104050
    Diclofenac impurity 8
    Diclofenac impurity 8 (Diclofenac impurity B) is an impurity of Diclofenac.
    Diclofenac impurity 8
  • HY-118226
    5,6,7,8-Tetrahydro-2-naphthoic acid
    		98.53%
    5,6,7,8-Tetrahydro-2-naphthoic acid is a synthetic intermediate useful for pharmaceutical synthesis.
    5,6,7,8-Tetrahydro-2-naphthoic acid
  • HY-W040886
    2-Bromo-6-nitrophenol
    		98.0%
    2-Bromo-6-nitrophenol is converted via 2-bromo-6-aminophenol to N-acetyl-2-bromo-6-aminophenol.
    2-Bromo-6-nitrophenol
  • HY-W018575
    Telmisartan impurity 17
    		99.92%
    Telmisartan impurity 17 is an impurity of Telmisartan.
    Telmisartan impurity 17